Working… Menu

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02571036
Recruitment Status : Recruiting
First Posted : October 8, 2015
Last Update Posted : November 20, 2020
Information provided by (Responsible Party):
Deciphera Pharmaceuticals LLC